Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cabergoline for prediabetes
ACTRN12613001121752Phase 2Recruiting
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of cabergoline in prediabetes (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Reversal of insulin resistance based on HOMA-IR and Improvement in insulin secretion based on HOMA-Beta. Started Jul 2013; status: recruiting.
02
Drugs
cabergoline
03
Conditions
prediabetes
Beyond the preview
Go deeper on ACTRN12613001121752.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613001121752.